MYCN-enhanced Oxidative and Glycolytic Metabolism Reveals Vulnerabilities for Targeting Neuroblastoma

In pediatric neuroblastoma, MYCN-amplification correlates to poor clinical outcome and new treatment options are needed for these patients. Identifying the metabolic adaptations crucial for tumor progression may be a promising strategy to discover novel therapeutic targets. Here, we have combined pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliynyk, Ganna, Ruiz-Pérez, María Victoria, Sainero-Alcolado, Lourdes, Dzieran, Johanna, Zirath, Hanna, Gallart-Ayala, Héctor, Wheelock, Craig E., Johansson, Henrik J., Nilsson, Roland, Lehtiö, Janne, Arsenian-Henriksson, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889365/
https://www.ncbi.nlm.nih.gov/pubmed/31670074
http://dx.doi.org/10.1016/j.isci.2019.10.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889365/
https://www.ncbi.nlm.nih.gov/pubmed/31670074
http://dx.doi.org/10.1016/j.isci.2019.10.020

Ejemplares similares